Summary
An 11-year-old girl, with the McCune-Albright syndrome, exhibited fibrous dysplasia of several bones, skin pigmentation, precocious puberty, growth hormone hypersecretion, acromegaly and hyperprolactinemia. Histologic, immunocytologic and ultrastructural investigation of the surgically-removed pituitary showed massive mammosomatotroph hyperplasia. Since no adenoma was found, the abundance of these bihormonal cells, capable of producing both growth hormone and prolactin, was implicated in the causation of growth hormone and prolactin excess. Somatoliberin overproduction and/or somatostatin and dopamine deficiency could not account for the hypophysial abnormality, since changes in secretory rates of these hypothalamic hormones would lead to proliferation of mature somatotrophs and lactotrophs, rather than mammosomatotrophs. In our patient, a congenital hypothalamic malfunction might have been accompanied by hypersecretion of an unidentified releasing factor, resulting in pathologic differentiation of the pituitary and mammosomatotroph hyperplasia. Alternatively, mammosomatotroph hyperplasia may have been due to an inherent genetic or embryonic defect affecting primarily the pituitary. According to this interpretation, the pituitary lesion represented yet another developmental error in the setting of the McCune-Albright syndrome.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albin J, Wu R (1981) Abnormal hypothalamic pituitary function in polyostotic fibrous dysplasia. Clin Endocrinol 14:435–443
Albright F, Butler AM, Hampton AO, Smith P (1937) Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. N Engl J Med 216:727–740
Benedict PH (1962) Endocrine features in Albright's syndrome (fibrous dysplasia of bone). Metabolism 11:30–45
Carr D, Mathie IK, Manners AR, Colman C (1979) Hyperprolactinaemia in a patient with the McCune-Albright syndrome. Br J Obstet Gynaecol 86:330–331
Chung KF, Alaghband-Zadek J, Guz A (1983) Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Evidence of hypothalamic dysfunction. Am J Dis Child 137:134–136
Frohman LA, Szabo M, Berelowitz M, Stachura ME (1980) Partial purification and characterization of a peptide with growth hormonereleasing activity from extrapituitary tumors in patients with acromegaly. J Clin Invest 65:43–54
Hall R, Warrick C (1972) Hypersecretion of hypothalamic releasing hormones: a possible explanation of the endocrine manifestations of polyostotic fibrous dysplasia (Albright's syndrome). Lancet 1:1313–1316
Halmi NS (1982) Occurrence of both growth hormone- and prolactin-immunoreactive material in the cells of human somatotropic pituitary adenomas containing mammotropic elements. Virchows Arch (Pathol Anat) 398:19–31
Halmi NS, Parsons JA, Erlandsen SL, Duello T (1975) Prolactin and growth hormone cells in the human hypophysis: a study with immunoenzyme histochemistry and differential staining. Cell Tissue Res 158:497–507
Horvath E, Kovacs K, Killinger DW, Smyth HS, Weiss MH, Ezrin C (1983) Mammosomatotroph cell adenoma of the human pituitary: a morphologic entity. Virchows Arch [Pathol Anat] 398:277–289
Jervis GA, Schein H (1951) Polyostotic fibrous dysplasia (Albright's syndrome). Report of a case showing central nervous system changes. Arch Pathol 51:640–650
Job JC, Garnier PE, Chaussain JL, Milhaud G (1972) Elevation of serum gonadotropins (LH and FSH) after releasing hormone (LH-RH) injection in normal children and in patients with disorders of puberty. J Clin Endocrinol Metab 35:473–476
Joishy SK, Morrow LB (1976) McCune-Albright syndrome associated with a functioning pituitary chromophobe adenoma. J Pediatr 89:73–75
Kovacs K, Horvath E, Ezrin C (1977) Pituitary adenomas. Pathol Annu 12 (part 2):341–382
Kovacs K, Horvath E, Ryan N (1981) Immunocytology of the human pituitary. In: DeLellis RA (ed), Diagnostic immunohistochemistry. New York, Masson Publ pp 17–35
Lichtenstein L, Jaffe HL (1942) Fibrous dysplasia of bone. A condition affecting one, several or many bones, the graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism or still other extraskeletal abnormalities. Arch Pathol 33:777–816
Lighthner ES, Penny R, Frasier SD (1975) Growth hormone excess and sexual precocity in polyostotic fibrous dysplasia (McCune-Albright syndrome): evidence for abnormal hypothalamic function. J Pediatr 87:922–927
Lipson A, Hsu TH (1981) The Albright syndrome associated with acromegaly: report of a case and review of the literature. Johns Hopkins Med J 149:10–14
MacMahon HE (1975) Albright's syndrome - thirty years later (Polyostotic fibrous dysplasia). In: Endocr Pathol Decennial 1966–1975. New York, Appleton-Century-Crofts
McCune DJ (1936) Osteitis fibrosa cystica: the case of a nine-year-old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 52:743–747
Polychronakos C, Tsoukas G, Ducharme JR, Letarte J, Collu R (1982) Gigantism and hyper-prolactinemia in polyostotic fibrous dysplasia (McCune-Albright syndrome). J Endocrinol Invest 5:323–326
Powell DGB (1976) Polyostotic fibrous dysplasia with acromegaly (Albright's syndrome). A case report. S Afr Med J 50:182–183
Scurry MT, Bicknell JM, Fajans SS (1964) Polyostotic fibrous dysplasia and acromegaly. Arch Intern Med 114:40–45
Sternberg WH, Joseph V (1942) Osteodystrophia fibrosa combined with precocious puberty and exophthalmic goiter. Pathologic report of a case. Am J Dis Child 63:748–783
Thannhauser SJ (1944) Neurofibromatosis (von Recklinghausen) and osteitis fibrosa cystica localisata et disseminata (von Recklinghausen). A study of a common pathogenesis of both diseases. Differentiation between “hyperparathyroidism with generalized decalcification and fibrocystic changes of the skeleton and osteitis fibrosa cystica disseminata.” Medicine 23:105–148
Thorner MO, Martin WH, Rogol AD, Morris JL, Perryman RL, Conway BP, Howards SS, Wolfman MG, MacLeod RM (1980) Rapid regression of pituitary prolactinomas during bromocriptine treatment. J Clin Endocrinol Metab 51:438–445
Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, Vale W, Horvath E, Kovacs K (1982) Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest 70:965–977
Thorner MO, Perryman RL, Rogol AD, Conway BP, MacLeod RM, Login IS, Morris JL (1981) Rapid changes of prolactinoma volume following withdrawal and reinstitution of bromocriptine. J Clin Endocrinol Metab 53:480–483
Tindall GT, Kovacs K, Horvath E, Thorner MO (1982) Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural and morphometric study. J Clin Endocrinol Metab 55:1178–1183
Warrick CK (1973) Some aspects of polyostotic fibrous dysplasia: possible hypothesis to account for the associated endocrinological changes. Clin Radiol 24:125–138
Wiggins JC Jr (1955) Polyostotic fibrous dysplasia with extraskeletal features. Report of a case with postmortem observations. NC Med J 16:520–527
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kovacs, K., Horvath, E., Thorner, M.O. et al. Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. Vichows Archiv A Pathol Anat 403, 77–86 (1984). https://doi.org/10.1007/BF00689340
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00689340